Position in PFE
as of Jun 30, 2026
· filed Jul 21, 2026
Position Value
$324,429
-$28,368 QoQ
Shares Held
13,473
+7.2% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#2,070
of 2,821 holders
Holding Since
Mar 2020
24 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Founders Capital Management holds $23,776,064 across 8 Drug Manufacturers - General names. PFE ranks #4 (1.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
46,663 | $11,851,002 | |
| 2 | ABBV |
AbbVie Inc.
|
25,101 | $6,316,415 | |
| 3 | MRK |
Merck & Co., Inc.
|
38,583 | $4,957,915 | |
| 4 | PFE |
Pfizer Inc
This page
|
13,473 | $324,429 | |
| 5 | AMGN |
Amgen Inc
|
409 | $148,107 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
1,500 | $86,430 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
512 | $64,686 | |
| 8 | OGN |
Organon & Co.
|
2,000 | $27,080 |
All Filings in PFE
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $324,429 | 13,473 | Shares | Sole | 2026-07-21 | |
| 2026-03-31 | $352,797 | 12,564 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $305,074 | 12,252 | Shares | Sole | 2026-01-15 | |
| 2025-09-30 | $377,104 | 14,800 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $356,449 | 14,705 | Shares | Sole | 2025-07-18 | |
| 2025-03-31 | $423,507 | 16,713 | Shares | Sole | 2025-04-08 | |
| 2024-12-31 | $587,825 | 22,157 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $733,252 | 25,337 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $695,498 | 24,857 | Shares | Sole | 2024-07-10 | |
| 2024-03-31 | $750,748 | 27,054 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $979,810 | 34,033 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $1,985,788 | 59,867 | Shares | Sole | 2023-10-10 | |
| 2023-06-30 | $2,274,563 | 62,011 | Shares | Sole | 2023-07-07 | |
| 2023-03-31 | $2,563,015 | 62,819 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $3,190,663 | 62,269 | Shares | Sole | 2023-01-09 | |
| 2022-09-30 | $2,723,316 | 62,233 | Shares | Sole | 2022-10-06 | |
| 2022-06-30 | $3,303,981 | 63,017 | Shares | Sole | 2022-07-20 | |
| 2022-03-31 | $3,518,444 | 67,963 | Shares | Sole | 2022-04-07 | |
| 2021-12-31 | $4,013,215 | 67,963 | Shares | Sole | 2022-01-21 | |
| 2021-09-30 | $2,933,798 | 68,212 | Shares | Sole | 2021-10-12 | |
| 2021-06-30 | $3,660,011 | 93,463 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $3,411,597 | 94,165 | Shares | Sole | 2021-06-09 | |
| 2020-12-31 | $3,662,263 | 99,491 | Shares | Sole | 2021-01-12 | |
| 2020-03-31 | $3,518,619 | 107,801 | Shares | Sole | 2020-04-22 | |
| No filing history on record for this holder in this stock. | ||||||